Navigation and service

"SafeVac" – App based capture of adverse effects after influenza vaccinations in a first field study

In a current study, a research team of the Helmholtz Centre for Infection Research (Helmholtz-Zentrum für Infektionsforschung, HZI) and the Paul-Ehrlich-Institut (PEI) is testing the smartphone app "SafeVac", designed to capture symptoms after an influenza vaccination. The purpose of this research project is to develop user-friendly reporting facilities to improve the safety of vaccines.

more: "SafeVac" – App based capture of adverse effects after influenza vaccinations in a first field study …

Zika virus vector vaccine protects the mother and the offspring in the mouse model

A vector vaccine against Zika virus based on the measles vaccine virus protects pregnant mice and their offspring against Zika virus infection and disease. At the same time this vaccine elicits an immune response against the measles virus comparable with that of the conventional measles vaccine.

more: Zika virus vector vaccine protects the mother and the offspring in the mouse model …

Availability of flu vaccines - report possible bottlenecks to the Paul-Ehrlich-Institut online

The Paul-Ehrlich-Institut (PEI), Federal Institute for Vaccines and Biomedicines, has been offering an online form for reporting suspected bottlenecks to vaccines since 10 October 2018 at www.pei.de/lieferengpaesse-verbrauchermeldung. We are currently calling on health professionals and consumers to let us know via this form if a flu vaccine is not available. The PEI can thus gain insights into which regions are facing bottlenecks for influenza vaccines.

This Page